Rybelsus 7 mg Tablets
  1. Home
  2. Rybelsus
  3. Rybelsus 7 mg Tablets

Rybelsus 7 mg Tablets

Rybelsus Semaglutide Tablets are prescription oral GLP-1 receptor agonist tablets indicated for improving glycemic control in adults with type 2 diabetes when used alongside diet and exercise. They provide once-daily oral administration without the need for injections. The tablet formulation offers a convenient treatment option for long-term diabetes management.

BUY NOW

Category

Rybelsus Semaglutide Tablets contain semaglutide, a GLP-1 receptor agonist that helps improve blood glucose control by stimulating glucose-dependent insulin secretion, suppressing glucagon release, slowing gastric emptying, and promoting satiety. The oral tablet formulation is designed for once-daily administration, providing an effective alternative to injectable GLP-1 therapies for eligible patients. Manufactured under stringent pharmaceutical quality standards, the tablets are supplied in blister packs for convenient dosing and storage. Rybelsus should be taken only under the supervision of a qualified healthcare professional according to the prescribed treatment plan.

Technical Specification

Specification Details
Product Name Rybelsus Semaglutide Tablets
Active Ingredient Semaglutide
Dosage Form Oral Tablets
Available Strengths 3 mg, 7 mg, 14 mg
Route of Administration Oral
Storage Store below 30°C in a dry place

Product Also Known As

Rybelsus Tablets, Semaglutide Oral Tablets, Oral Semaglutide Tablets, Rybelsus Oral Tablets, GLP-1 Oral Tablets, Semaglutide Diabetes Tablets, Once-Daily Semaglutide Tablets